Innovita Biological Technology Co. Ltd. A (688253) — Capital Reinvestment Ratio
Innovita Biological Technology Co. Ltd. A (688253) has a Capital Reinvestment Ratio of 0.16x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥193.13 Million) in capital expenditures (CN¥31.13 Million). See net asset quality index of Innovita Biological Technology Co. Ltd. to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Innovita Biological Technology Co. Ltd. A Capital Reinvestment Ratio (2020–2025)
This chart tracks Innovita Biological Technology Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods. Check 688253 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Innovita Biological Technology Co. Ltd. A (2020–2025)
Year-by-year Capital Reinvestment Ratio for Innovita Biological Technology Co. Ltd. A from 2020 to 2025. For live market cap and broader valuation context, see 688253 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥193.13 Million | CN¥31.13 Million | ▲ +36.2% |
| 2024 | 0.12x | CN¥305.46 Million | CN¥36.16 Million | ▲ +81.3% |
| 2023 | 0.07x | CN¥259.85 Million | CN¥16.97 Million | ▼ -85.7% |
| 2022 | 0.46x | CN¥126.43 Million | CN¥57.71 Million | ▼ -23.9% |
| 2021 | 0.60x | CN¥106.27 Million | CN¥63.75 Million | ▲ +400.3% |
| 2020 | 0.12x | CN¥639.82 Million | CN¥76.71 Million | — |